Our topical polls and independent studies provide free pharmaceutical and health industry insights from healthcare professionals and patient perspectives. The infographic accompanying each article can be downloaded and shared with attribution.
Virtual medical conferences are on the rise, but are they here to stay? As a result of the pandemic over the past year, conference organizers and medical brands were set scrambling to find a solution to limit cancelations of key medical conferences. Resulting virtual platforms advanced quickly to emulate the face-to-face conference experience through a digital means. While many virtual medical conferences were successful, in terms of strong participation levels to many key events both national and international, questions remained as to how well they met the needs of physicians, other healthcare providers and the pharmaceutical and medical device companies...
The detailing of healthcare providers through virtual means has become a staple for pharmaceutical brands and is essential for any go-to-market strategy. When face-to-face detailing was put on hold this past year, healthcare providers began experiencing an even greater volume of requests for virtual interactions. For pharma brand teams, ensuring your approach to digital communications matches with the preferences of providers is important in helping your messages get through to your target prescribers. In our latest quick poll, conducted in March 2021, MD Analytics sought to gain clarity around current remote detailing preferences and identify the components of an “ideal”...
Each year, providers and health industry professionals travel from locations around the world to share and discuss the latest developments in medical care. For several years now, conferences have been experimenting with digital features that allow participants to engage remotely, avoiding the burdens of travel. However, the scope of content available to digital participants had often been limited and physician adoption was low....
Our 5-minute online survey conducted in the fall of 2020 sought to gain clarity around remote detailing. This study was conducted with 339 Canadian physicians who are members of the MD Analytics healthcare panel and the results provide actionable recommendations on how to form a more 'ideal' pharma remote detail....
The COVID-19 crisis has significantly impacted physicians’ practices; but how and to what extent? Physicians have been managing significant workloads, while learning on the fly how to navigate and setup virtual meetings. Maintaining high levels of patient care while minimizing in-person interactions has also been challenging....
Strong online advertising and messaging are key to maximizing impact of any marketing campaign. With recent restrictions on in-person interactions, online advertising and messaging play an even greater role in reaching physicians. Our findings from a survey of n=227 Canadian physicians show that 82% of Canadian physicians have increased their use of online platforms as a result of COVID-19, 48% significantly so....
Physicians recognize that new medications often can be quite valuable for their patients and are eager to add them to their armamentarium. However, they do not always end up prescribing these new medications as much as they initially plan or as early as they would like. There are many reasons that can explain this discrepancy....
Patients are an increasingly influential stakeholder within the healthcare industry as more medical information becomes available online than ever before. This independent market research study conducted by MD Analytics takes a closer look at patients in order to better understand their motivations and predict their behaviours within this complex landscape....
Physicians are using social media in their personal and professional lives, especially younger physicians. However, the pharma industry should be aware of barriers to using social media as a means of interacting professionally with physicians, such as the perceived reliability of online information....
Measuring customer engagement in pharmaceutical market research can be challenging as physicians usually prefer to not be seen as “associated” with any given pharmaceutical company. However, as demonstrated by our customer engagement syndicated study, it is undeniable that stronger levels of physician engagement exist among pharmaceutical companies which can lead to more positive outcomes for their associated brands....
Real World Evidence (RWE) is a growing area of research that, pivoting from the rigorously controlled standards of randomized controlled trials (RCT), is based on a model driven by real world patient data. Real World Evidence stems primarily from an observational analysis of a sample in a less controlled environment. Focused on the efficacy and outcomes of therapies in a real world setting, RWE provides a unique lens not attainable from traditional clinical trial research....
In the healthcare system, a patient’s journey to optimal care presents many obstacles. There are numerous steps involved from the onset of a medical condition to the moment when satisfactory results are achieved. This healthcare survey seeks to reveal key opportunities within the patient journey that would assist patients along their way and ultimately improve outcomes. Further healthcare market research could also be conducted by disease area to dig deeper into these insights....
Over a 3-day period, MD Analytics surveyed 1,000 Canadians that are responsible for making health-related decisions. It was found that respondents are often choosing to not to see a physician when health-related scenarios arise, citing self-diagnosis or lack of convenience as their key reasons. Respondents are also strongly likely to visit a walk-in clinic instead of their family physician, with convenience again mentioned as the key reason....
Qualitative research can provide a greater understanding of physicians’ attitudes and behaviours than quantitative methodologies, however increased demands on physician time may cause some to refuse participating. Determining the optimal study design and appropriate recruitment techniques can help make physicians more willing to participate....
Biological drugs, protein-based products derived from living cells using biotechnology, have been used since the 1990’s as a treatment option for cancer patients. Since 2009, biosimilar therapies (therapeutically equivalent subsequent entry biologics) have been available in different therapeutic areas in Canada, and are now on the verge of becoming available for use in oncology....
The Canadian Senate recently passed Bill C-46 which will allow for the legal use of recreational cannabis across Canada by Fall 2018. While some physicians anticipate this new legislation will impact their practices with patients electing to try recreational cannabis instead of more traditional prescription medications or medical cannabis, others anticipate increases in patient visits related to dependence and psychotic symptoms....
Dental professionals turn to traditional information channels most often when sourcing information on manufacturer products and continuing education. However, more innovative tools such as online and digital offerings continue to grow in importance, especially among newer dental professionals. Find out how to make sure your future outreach efforts are ready for the next generation of dental professionals....
Traditional in-person continuing health education (CHE) programs remain the most attended format for Canadian physicians practitioners, however preferred sources of CHE vary widely by generation. As educational activities are an important channel to communicate important scientific data about new treatment options, program success will benefit from a tailored approach to CHE delivery....
Ready to explore how data-driven insights can accelerate your pharmaceutical research? Connect with our team to discuss your goals.
